Technology
Immunovia CEO And Board Members Announce Intention To Fully Exercise Their TO2 Warrants
(MENAFN - PR Newswire) LUND, Sweden, Dec. 18, 2024 /PRNewswire/ --Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced its CEO and board ...
By: menafn
- Dec 18 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS